
Episode 34: General Atlantic's Brett Zbar
BioVenture VoiCes with Chris Garabedian
00:00
Oncology and INI risk preferences
Brett says GA prefers de-risked biology or strong teams, often seeking clinical data before investing in oncology.
Play episode from 51:57
Transcript


